. Author manuscript; available in PMC: 2016 Jan 1.

Published in final edited form as: Am J Med. 2014 Aug 10;128(1):90.e1–90.e7. doi: 10.1016/j.amjmed.2014.07.027

Table III.

Predictors of annual hepatocellular carcinoma surveillance^*

Variable	Multivariate Analysis		Effect size
Variable	OR	95% CI	Effect size
Male gender	1.63	1.00 – 2.67	15.6% vs. 9.7%
Two or more hepatology visits per year	1.99	1.28 – 3.10	19.3% vs. 10.9%
Nonalcoholic steatohepatitis etiology	0.41	0.17 – 0.99	5.7% vs. 14.7%
Caucasian race^**	1.21	0.76 – 1.92	13.8% vs. 12.8%
Insurance status^**	1.18	0.76 – 1.84	13.8% vs. 13.2%
Child Pugh class C cirrhosis^**	0.70	0.39 – 1.23	11.0% vs. 14.1%

Annual surveillance was defined as at least one ultrasound for surveillance purposes every 12 months

^**

Race, insurance status, and Child Pugh class were entered into multivariate model given a priori importance